GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool
All cost breakdowns

Mounjaro Price in India 2026

Tirzepatide for Type 2 Diabetes + Obesity · Manufactured by Eli Lilly · Last reviewed 12 May 2026

The short answer

Mounjaro in India costs ₹14,000–27,500 per month, scaling with dose from 2.5 mg starter to 15 mg max. The 5 mg early-maintenance dose runs around ₹14,500/month; the 10 mg dose for active weight loss is ₹20,000–22,000; the 15 mg target dose costs ₹25,000–27,500. No Indian generic tirzepatide exists — patents extend to ~2030. Insurance coverage is exceptionally rare.

Not sure if Mounjaro is right for you?

Take the 5-minute Indian-guideline assessment.

Take the free assessment →

Mounjaro price by dose

MRP and observed pharmacy pricing across major Indian retail + online channels. Hospital pharmacies typically charge MRP; online pharmacies discount 5-12%.

DosePens/monthMRP per penMonthly MRPTypical pharmacy
2.5 mg (starter, 4 weeks)4 pens (1 weekly)₹3,500₹14,000₹13,500–14,500
5 mg (early maintenance)4 pens₹3,625₹14,500₹14,000–15,000
7.5 mg4 pens₹4,500₹18,000₹17,500–18,500
10 mg (standard weight loss)4 pens₹5,500₹22,000₹21,000–22,500
12.5 mg4 pens₹6,250₹25,000₹24,500–25,500
15 mg (max approved)4 pens₹6,875₹27,500₹26,500–28,000

Where to buy Mounjaro in India

Mounjaro is a Schedule H prescription drug requiring a doctor's prescription. Eli Lilly distributes through: (1) major retail pharmacy chains (Apollo, MedPlus, Wellness Forever) — stock is limited in tier-2 cities; (2) hospital pharmacies, especially endocrinology and diabetes specialty centers; (3) online prescription pharmacies (1mg, PharmEasy, Apollo 24/7, Tata 1mg) with prescription upload. Cold-chain handling is critical for tirzepatide — confirm refrigerated shipping. Avoid sources offering Mounjaro at >30% discount; counterfeit pens have appeared in Indian markets since the March 2025 launch.

Does insurance cover it?

Mounjaro coverage by Indian health insurance is exceptionally rare given the high monthly cost. When prescribed primarily for type 2 diabetes management (e.g., HbA1c >8% despite metformin + other therapies), some chronic-care policies (Star Health Diabetes Safe Plan, ManipalCigna ProHealth) may offer partial reimbursement. For pure weight-loss indication, expect zero coverage. Corporate executive medical plans have the highest probability of partial coverage. Verify with insurer in writing before assuming any reimbursement.

Hidden costs to factor in

The Mounjarosticker price isn’t the full story. These additional costs are typical for an India-based course of therapy.

  • +Endocrinologist consultation (₹1,500-4,000 first visit, ₹800-2,000 follow-ups)
  • +Pre-treatment labs: HbA1c, fasting glucose, lipid profile, LFT, KFT, TSH, plus diabetes-relevant antibodies if newly diagnosed (~₹2,500-4,500)
  • +Quarterly lab monitoring (~₹2,000/quarter)
  • +KwikPen needle replacements (~₹200/month)
  • +Refrigerated shipping (₹100-400) for home delivery
  • +Nutritionist consults during titration (₹2,000-3,000/session, 2-3 sessions recommended)
  • +Body-composition tracking via DEXA (₹3,000-5,000) if monitoring muscle vs fat
  • +Emergency room visits if severe GI symptoms occur (rare but ₹15,000-50,000)

Frequently asked questions

Why is Mounjaro so much more expensive than Ozempic and Wegovy?+
Three reasons: (1) tirzepatide is a more complex dual-agonist molecule, harder to manufacture; (2) Eli Lilly launched in India in March 2025 at premium pricing reflecting US/UK price benchmarks; (3) no Indian generic competition yet — patent protection runs to ~2030. Wegovy faces competition from 10+ Indian semaglutide generics; Mounjaro has none.
When will Indian generic tirzepatide arrive?+
Likely 2028-2030. Eli Lilly's tirzepatide patents in India extend several more years, and there's no indication of compulsory licensing yet. When generics arrive, expect prices to drop 60-80% (mirroring what happened with semaglutide — Ozempic at ₹8,000+ vs Indian generics at ₹1,290+). Until then, Mounjaro is the only tirzepatide option in India.
Is Mounjaro really worth ₹25,000+/month compared to ₹10,000 for Wegovy?+
Depends on your weight-loss target and clinical urgency. Mounjaro at 15 mg produces ~22% weight loss vs Wegovy's ~15% — about a 50% efficacy improvement at ~2-3× the price. For severe obesity (BMI ≥35) where outcomes are clinically urgent, the cost is often justified. For BMI 28-32, Wegovy at maximum dose delivers 80% of the benefit at half the cost.
What's the total annual cost of Mounjaro therapy in India?+
For a patient on 10 mg maintenance (typical weight-loss dose): 12 × ₹22,000 = ₹2,64,000/year for Mounjaro alone. Add ₹30,000-50,000 in consults, labs, nutrition, and supplies. Total annual cost: ₹3,00,000-3,15,000. For 15 mg maximum dose: closer to ₹3,40,000-3,60,000/year. International comparison: US Mounjaro list price runs $1,200/month (₹1,00,000) — Indian Mounjaro is roughly 1/4 the US price.
Is the KwikPen or single-dose vial cheaper?+
Per-dose, they're priced similarly in India — Eli Lilly hasn't introduced significant differentiated pricing between the formats yet. The KwikPen is more convenient (pre-filled, no measuring); the vial is preferred by patients who want flexibility on dosing or are managing supply during stock shortages. Most Indian patients default to the KwikPen.
Can I split Mounjaro doses to save money?+
Technically possible with the vial (drawing partial doses), but not recommended. Splitting changes the titration pattern, increases injection technique errors, and isn't supported by clinical trials. Many Indian endocrinologists discourage it. If cost is the issue, a better strategy is to start lower (5 mg maintenance instead of 10 mg) and titrate up only if needed, rather than splitting higher-dose pens.
Is there a patient access program from Eli Lilly in India?+
Eli Lilly's "PA-Connect" patient access program in India is limited compared to the US. Some chronic-disease support programs offer Mounjaro at reduced rates for verified low-income patients, but the criteria are strict and the bandwidth is small. Ask your endocrinologist if you might qualify, but don't plan around it.

Related cost breakdowns

Ozempic price India

Semaglutide for Type 2 Diabetes

Wegovy price India

Semaglutide for Obesity (Chronic Weight Management)

Is Mounjaro right for your profile?

The 5-minute Indian-guideline assessment uses your BMI, comorbidities, and lab values to recommend an evidence-based starting point.

Start the free assessment →

Prices reflect public MRP and observed pharmacy pricing as of May 2026. Actual pricing may vary by city, pharmacy chain, and time. Mounjaro is a Schedule H drug — only a registered medical practitioner can prescribe it.